MENU
Showcases Stock ranks Forex

Onconova Therapeutic (ONTX)
7.07  -0.08 (-1.12%) 06-11 16:00
Open: 7.15 Pre. Close: 7.15
High: 7.2365 Low: 6.97
Volume: 595,217 Market Cap: 1,673M
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. The company is headquartered in Newtown, Pennsylvania and currently employs 25 full-time employees. The firm operates through the identification and development of oncology therapeutics segment. The company is focused on discovering and developing small molecule drug candidates to treat cancer. The firm has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells. The company has over three clinical-stage product candidates and various preclinical programs that target kinases, cellular metabolism or cell division in preclinical development. The firm's lead product candidate, rigosertib, is being tested in both intravenous (IV) and oral formulations as a single agent, and the oral formulation is also being tested in combination with azacitidine, in clinical trials for patients with myelodysplastic syndromes (MDS), and related cancers. Its other product candidates include Briciclib and Recilisib.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 7.249 - 7.294 7.294 - 7.326
Low: 6.864 - 6.92 6.92 - 6.959
Close: 6.996 - 7.078 7.078 - 7.136
Stock Technical Analysis
Overall:     
Target: Six months: 14.66
One year: 19.27
Support: Support1: 6.17
Support2: 5.13
Resistance: Resistance1: 12.55
Resistance2: 16.50
Pivot: 7.05
Moving Averages: MA(5): 7.03
MA(20): 8.21
MA(100): 12.83
MA(250): 9.69
MACD: MACD(12,26): -0.92
Signal(12,26,9):
%K %D: %K(14,3): 15.34
%D(3): 11.37
RSI: RSI(14): 43.41
52-Week: High: 28.95
Low: 2.85
Change(%): -21.4
Average Vol(K): 3-Month: 454276
10-Days: 158492
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

ONTX has closed below upper band by 49.3%. Bollinger Bands are 66.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to ONTX's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
Wed, 09 Jun 2021
Is Onconova Therapeutics Inc (ONTX) a Good Buy in the Healthcare Sector? - InvestorsObserver

Fri, 04 Jun 2021
Onconova Therapeutics, Inc. (ONTX) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Thu, 03 Jun 2021
Onconova Therapeutics Announces Upcoming Presentation at 2021 BIO Digital - GlobeNewswire

Wed, 02 Jun 2021
Should You Buy Onconova Therapeutics Inc (ONTX) Stock on Wednesday? - InvestorsObserver

Tue, 01 Jun 2021
Onconova Therapeutics Announces the Appointment of Mark Gelder, M.D., as Chief Medical Officer - GlobeNewswire

Mon, 24 May 2021
Should You Accumulate Onconova Therapeutics Inc (ONTX) in Biotechnology Industry? - InvestorsObserver

Financial Analysis
Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  Nasdaq Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 236.61
Shares Float (M) 221.88
% Held by Insiders 0.55
% Held by Institutions 15.08
Shares Short (K) 6020
Shares Short Prior Month (K) 11620
Stock Financials
EPS -0.140
Book Value (p.s.) 0.030
Profit Margin
Operating Margin -10819.48
Return on Assets (ttm) -71.6
Return on Equity (ttm) -283.5
Qtrly Rev. Growth 90.0
Gross Profit (p.s.) 0.001
Sales Per Share 0.001
EBITDA (p.s.) -0.106
Qtrly Earnings Growth
Operating Cash Flow (M) -23.07
Levered Free Cash Flow (M) -13.54
Stock Valuation
PE Ratio -50.50
PEG Ratio
Price to Book value 235.67
Price to Sales 7241.70
Price to Cash Flow -72.51
Stock Dividends
Dividend
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator